TELESIS BIO INC TBIO
COM NEW · Common Stock · CUSIP 192003200
1
institutional holders
-10 vs Q2 2024
46.6k
shares reported held*
$178.5kreported value*
1 new
0 added
0 reduced
11 sold out
net sold ≈ $2.0m (-516.3k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.83.
Trends to Q3 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q2 2024 | 11 |
| Q3 2024 | 1 |
Biggest buyers
| CLEAR STREET LLC | New | +46.6k |
Biggest sellers
| Northpond Ventures, LLC | Sold out | -546.9k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -12.9k |
| UBS Group AG | Sold out | -2.5k |
| BANK OF AMERICA CORP /DE/ | Sold out | -338 |
| Dynamic Wealth Strategies, LLC | Sold out | -138 |
| JPMORGAN CHASE & CO | Sold out | -62 |
| ROYAL BANK OF CANADA | Sold out | -24 |
| Qube Research & Technologies Ltd | Sold out | -23 |
| BNP PARIBAS FINANCIAL MARKETS | Sold out | -2 |
| CITIGROUP INC | Sold out | -1 |
Holders, Q3 2024
| Manager | Shares | Change |
|---|---|---|
| CLEAR STREET LLC 0.00% of their portfolio | 46.6k $178.5k | New |